| Travis Whitlock, PT | |
|
3 Delaware Dr, New Hyde Park, NY 11042-1116 | |
| (516) 622-6161 | |
| Not Available |
| Full Name | Travis Whitlock |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 3 Delaware Dr, New Hyde Park, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104014950 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 021858 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Travis Whitlock, PT 3 Delaware Dr, New Hyde Park, NY 11042-1116 Ph: (516) 622-6161 | Travis Whitlock, PT 3 Delaware Dr, New Hyde Park, NY 11042-1116 Ph: (516) 622-6161 |
News Archive
Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced the release of the iDimerize inducible dimerization systems. Based on the widely used ARGENT™ technology developed by ARIAD Pharmaceuticals, Inc., the iDimerize systems enable precise, real-time control of protein-protein interactions using specific cell-permeable chemical ligands, called dimerizers.
Millennium: The Takeda Oncology Company today announced that Phase II results of a clinical trial examining VELCADE (bortezomib) in patients with previously untreated aggressive lymphoma were published in the Journal of Clinical Oncology.
The molecular structure of a protein involved in Alzheimer's disease - and the surprising discovery that it binds cholesterol - could lead to new therapeutics for the disease, Vanderbilt University investigators report in the June 1 issue of the journal Science.
Celltrion Group today announced plans to expand its diagnostic portfolio for SARS-CoV-2, the virus causing COVID-19, in its efforts to improve access to COVID-19 testing and help prevent the further spread of coronavirus infection worldwide.
Pfizer announced today that the European Commission has approved Vyndaqel (tafamidis) for the treatment of Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP) in adult patients with stage 1 symptomatic polyneuropathy.
› Verified 8 days ago
Mohamed Mansour, PHYSICAL THERAPIST Physical Therapist Medicare: Medicare Enrolled Practice Location: 5 Dakota Dr Ste 200, New Hyde Park, NY 11042 Phone: 718-281-8521 | |
Bob Chang, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1991 Marcus Ave, New Hyde Park, NY 11042 Phone: 516-467-8730 | |
Dennis William Treubig, D.P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2800 Marcus Ave, New Hyde Park, NY 11042 Phone: 516-622-6161 | |
Dr. Anish Philip Mathew, PT, MPT (NEURO), DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1605 Hillside Ave, New Hyde Park, NY 11040 Phone: 516-616-0942 Fax: 516-616-0943 | |
Sebi Ann Varghese, D.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 18 Evans St, New Hyde Park, NY 11040 Phone: 516-458-9171 | |
Saichellam S Nattu, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1929 New Hyde Park Rd, New Hyde Park, NY 11040 Phone: 516-233-2534 | |
Maritess Parrel Sagrado, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1979 Marcus Ave Ste 204, New Hyde Park, NY 11042 Phone: 516-327-4681 |